All
FDA Should Be Empowered to Request Evidence for Structure-Function Claims, GAO Suggests
January 18th 2011Claiming that FDA is currently hampered in evaluating “potentially false or misleading structure/function claims,” the U.S. Government Accountability Office (GAO) has recommended in a new report that the agency be given the power to request evidence of substantiation from companies.
Supreme Court Mulls Testimony About AERs in Zicam Case
January 12th 2011Should drug and supplement companies be required to alert investors whenever any adverse-event report (AERs) over a product arises-in case an AER is predictive of a larger problem with the product that could devalue shareholder stocks?
OmniActive Expands Consumer Education for Eye-Health Ingredients
January 11th 2011OmniActive Health Technologies (Short Hills, NJ) has developed videos and additional marketing materials to educate consumers and health professionals about the importance of supplementing with proper amounts of lutein and zeaxanthin isomers.